At eGenesis, we are committed to ending the global transplant shortage and transforming the treatment of organ failure. We are bringing that vision closer to reality with lead programs in kidney and islet cell transplantation.
Leadership
Mike Curtis, Ph.D.
President & Chief Executive Officer
Eliezer Katz, M.D., FACS
Chief Medical Officer
Jennifer Bergheiser
Chief Business Officer
Knut Niss, Ph.D.
Chief Technology Officer
Elizabeth Roberts
Chief People Officer
Susan Low, Ph.D.
SVP, Head of Development
Wenning Qin, Ph.D.
SVP, Head of Research
Luis Queiroz, D.V.M.
Chief Scientific Officer of eGenesis Wisconsin
Tracy Chen, M.D.
VP, Therapeutic Development
Julie Hagan
VP, Regulatory Affairs
Jim Olesen, J.D., Ph.D.
Head of Intellectual Property
Kathryn Stiede
Head of Clinical Operations
Michele Youd, Ph.D.
Senior Director of Immunology
Michael Cohen
Associate General Counsel
Board of Directors
Steven Gillis, Ph.D.
Board Chairman
Paul Sekhri
Board Director
Rahul Kakkar M.D.
Board Director
Lucio Iannone, Ph.D.
Board Director
Kathleen Fanning
Board Director
Mark Pruzanski, M.D.
Board Director
Sarah Schlesinger, M.D.
Board Director
Brad Smith
Board Director
Julie Sunderland
Board Director
Albert (Al) Wiegman
Board Director